Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    BIIB033 | Biogen [Lead] | Phase 1
Show Display Options
Rank Status Study
1 Completed Safety Study of BIIB033 in Subjects With Multiple Sclerosis
Conditions: Relapsing-Remitting Multiple Sclerosis;   Multiple Sclerosis
Interventions: Drug: BIIB033;   Drug: Placebo
2 Completed BIIB033 Single Ascending Dose Study in Healthy Volunteer Subjects
Condition: Healthy
Interventions: Drug: BIIB033;   Drug: Placebo

Indicates status has not been verified in more than two years